Slovenia vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Slovenia
0
in 2018
United States of America
0.2907
in 2018
Slovenia rank
15th
United States of America rank
14th
Proportion of isolates with decreased susceptibility or resistance over time
- Slovenia
- United States of America
How they compare
United States of America currently reports 0.2907 against 0 in Slovenia, a difference of 0.2907.
The two have swapped places 5 times across 10 shared years of data; in 2009 it was Slovenia ahead.
Slovenia ranks 15th and United States of America ranks 14th of 27 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Slovenia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.33 | 0.7993 | 7.53 | Slovenia |
| 2010s | 3.7 | 0.3382 | 3.37 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Slovenia or United States of America?
- United States of America, at 0.2907 against 0 in Slovenia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Slovenia and United States of America?
- 0.2907, with United States of America ahead.
- How many years of comparable data are there for Slovenia and United States of America?
- 10 years are reported by both, from 2009 to 2018.
- How do Slovenia and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Slovenia ranks 15th and United States of America ranks 14th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.